IN2014DN07316A - - Google Patents

Info

Publication number
IN2014DN07316A
IN2014DN07316A IN7316DEN2014A IN2014DN07316A IN 2014DN07316 A IN2014DN07316 A IN 2014DN07316A IN 7316DEN2014 A IN7316DEN2014 A IN 7316DEN2014A IN 2014DN07316 A IN2014DN07316 A IN 2014DN07316A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Kenneth Smith
Original Assignee
Oklahoma Med Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oklahoma Med Res Found filed Critical Oklahoma Med Res Found
Publication of IN2014DN07316A publication Critical patent/IN2014DN07316A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56944Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Gram-positive bacteria
    • C07K16/1275Streptococcus (G)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/90Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
    • G01N2333/3156Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae [Pneumococcus]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/10Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IN7316DEN2014 2012-02-01 2014-08-30 IN2014DN07316A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261593654P 2012-02-01 2012-02-01
PCT/US2013/021381 WO2013115962A2 (en) 2012-02-01 2013-01-14 Human streptococcus pneumoniae antibodies and uses therefor

Publications (1)

Publication Number Publication Date
IN2014DN07316A true IN2014DN07316A (de) 2015-04-24

Family

ID=48870421

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7316DEN2014 IN2014DN07316A (de) 2012-02-01 2014-08-30

Country Status (8)

Country Link
US (3) US9279815B2 (de)
EP (1) EP2810078A4 (de)
JP (1) JP2015508755A (de)
CN (1) CN104364650B (de)
AU (2) AU2013215630B2 (de)
CA (1) CA2863607A1 (de)
IN (1) IN2014DN07316A (de)
WO (1) WO2013115962A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9279815B2 (en) * 2012-02-01 2016-03-08 Oklahoma Medical Research Foundation Human Streptococcus pneumoniae antibodies and uses therefor
US10209254B2 (en) 2013-10-09 2019-02-19 University Of Rochester Chips, detection systems, and methods for multiplex pneumococcus serology
US10259865B2 (en) * 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
WO2018222741A1 (en) * 2017-05-31 2018-12-06 Oklahoma Medical Research Foundation Bispecific antibodies for the treatment of streptococcus pneumonia
KR20200097134A (ko) * 2019-02-07 2020-08-18 에스케이바이오사이언스(주) 교차반응이 없는 폐렴구균 항혈청 및 이의 제조방법
CN121064323A (zh) * 2025-09-19 2025-12-05 瑞洛薇(上海)科技有限公司 一种治疗肺部感染的多克隆抗体及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002079254A1 (en) * 2001-03-29 2002-10-10 Janoff Edward N Human monoclonal antibodies against capsular polysaccharides of streptococcus pneumoniae
JP2005519580A (ja) 2001-05-16 2005-07-07 アルバート アインシュタイン カレッジ オブ メディシン オブ イエシバ ユニバーシティ 非ヒト動物由来のヒト抗肺炎球菌抗体
CN101163499A (zh) * 2005-02-11 2008-04-16 Ace生物科学公司 表面定位的肺炎链球菌多肽
WO2009012588A1 (en) * 2007-07-23 2009-01-29 Sanofi Pasteur Limited Immunogenic polypeptides and monoclonal antibodies
US20110053793A1 (en) * 2007-12-21 2011-03-03 Alberto Monasterio Methods and products for identifying strains of bacteria
JP5204036B2 (ja) * 2009-05-28 2013-06-05 旭化成株式会社 肺炎球菌の検出方法
ES2649370T3 (es) * 2011-06-06 2018-01-11 Nationwide Children's Hospital, Inc. Método de detección diagnóstica basado en la proteómica para sinusitis crónica
US9279815B2 (en) * 2012-02-01 2016-03-08 Oklahoma Medical Research Foundation Human Streptococcus pneumoniae antibodies and uses therefor
WO2018222741A1 (en) * 2017-05-31 2018-12-06 Oklahoma Medical Research Foundation Bispecific antibodies for the treatment of streptococcus pneumonia
WO2020070461A1 (en) * 2018-10-04 2020-04-09 Secretary of State for Health and Social Care Immunoassay for detection of streptococcus pneumoniae serotypes

Also Published As

Publication number Publication date
WO2013115962A3 (en) 2014-10-23
JP2015508755A (ja) 2015-03-23
US9279815B2 (en) 2016-03-08
US20160178626A1 (en) 2016-06-23
US20130195876A1 (en) 2013-08-01
HK1206812A1 (en) 2016-01-15
CN104364650A (zh) 2015-02-18
AU2013215630A1 (en) 2014-09-18
AU2013215630B2 (en) 2016-05-26
CN104364650B (zh) 2017-11-21
US12352749B2 (en) 2025-07-08
US11567077B2 (en) 2023-01-31
US20230213512A1 (en) 2023-07-06
CA2863607A1 (en) 2013-08-08
EP2810078A4 (de) 2016-02-17
WO2013115962A2 (en) 2013-08-08
EP2810078A2 (de) 2014-12-10
AU2016219587A1 (en) 2016-09-08

Similar Documents

Publication Publication Date Title
BR122017012014A2 (de)
BR112014024002A2 (de)
BR112014017614A2 (de)
BR112014017592A2 (de)
BR112014017607A2 (de)
BR112014018608A2 (de)
BR112015011478A2 (de)
BR112014023589A2 (de)
AR092201A1 (de)
BR112014019762A2 (de)
BR112014019877A2 (de)
BR112013027865A2 (de)
BR112014017609A2 (de)
BR112014019248A2 (de)
BR112014017588A2 (de)
BR112014013184A8 (de)
BR112014017618A2 (de)
BR112014017623A2 (de)
BR112014021908A2 (de)
BR112014017621A2 (de)
BR112014017622A2 (de)
BR112014018505A2 (de)
CH708180A4 (de)
BR112014018216A2 (de)
BR112014017671A2 (de)